by Michael A. Carrier, Charles Duan and S. Sean Tu Carvedilol could be the poster child for how to lower drug prices. Since 2007, more than 20 million patients with cardiovascular conditions have enjoyed generic versions of the popular beta-blocker, which cost 2 cents a dose compared ...
by Rekha Basu A grim-faced doctor walks into an examining room where an anxious white-haired woman sits on the table, awaiting news. “Mrs. Smith, I have your test results here,” the doctor announces as the woman smiles up at him. “The news isn’t good.” Perhaps you’ve ...
In rejecting the pared down Build Back Better Act, Sen. Joe Manchin made clear that the only provision he still supports is codifying Medicare’s ability to negotiate prescription drug costs. Such a law would undoubtedly help hundreds, if not thousands, of West Virginians to contain the ...
by Lynn Schmidt Three centrist cheers for Sen. Joe Manchin III. Manchin’s stance on three key issues may be unpopular with some of his Democratic colleagues but they are popular with Americans. Manchin recently has met the ire of Democrats in the inflation-versus-climate action ...
by Peter Neumann, Joshua Cohen and Daniel Ollendorf Mark Cuban, the billionaire “Shark Tank” celebrity and Dallas Mavericks owner, is getting attention again — this time for his Mark Cuban Cost Plus Drug Co., which seeks to reduce prescription drug prices for Americans. A new ...
Funds shouldn’t be used for climate change By Elliot Simon Sen. Joe Manchin spent much of last year battling the Democrats’ multi-trillion-dollar “Build Back Better” package. Thankfully that monstrosity of a bill is largely behind us. But now, Manchin is putting forward ...